NADH is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-05-21. Numbers and descriptions here follow the published literature rather than marketing material.
Research on NAD+ spans biochemistry, aging biology, and metabolism. Studies often examine how NAD+ levels change with age, diet, exercise, or disease states, and whether precursor supplementation alters those levels. Findings in animal models do not automatically translate to humans, and measurement methods vary across studies. Questions about tissue-specific effects, long-term consequences, and causal relationships remain open. NAD+ itself is not established as a single therapeutic agent with a broad clinical role.
Nicotinamide adenine dinucleotide, abbreviated NAD+, is a dinucleotide composed of two nucleotides joined by phosphate groups. One nucleotide contains adenine; the other contains nicotinamide. The molecule exists in oxidized (NAD+) and reduced (NADH) forms, and the reversible hydride transfer between them underlies many metabolic oxidation-reduction reactions. In cells, NAD+ serves as an electron acceptor in pathways such as glycolysis, the citric acid cycle, and oxidative phosphorylation. Its concentration and redox ratio vary by compartment, tissue, and metabolic state.
Beyond redox chemistry, NAD+ is consumed as a substrate by enzymes that transfer ADP-ribose or remove acetyl groups. Sirtuins use NAD+ in deacylation reactions, poly(ADP-ribose) polymerases use it in DNA damage responses, and CD38 hydrolases convert it to signaling metabolites. Because these enzymes compete for the same pool, changes in NAD+ availability can influence multiple cellular processes. The relative contribution of each consumption route differs by cell type and condition, and precise quantitative links remain an active area of study.
Quality control for NAD+ relies on identity, purity, and functional tests. A certificate of analysis may report high-performance liquid chromatography purity, ultraviolet spectrum, water content, and residual solvents. Because NAD+ is hygroscopic, gravimetric values can shift as material absorbs water, so purity should be interpreted alongside storage history. Mass spectrometry confirms molecular identity, while enzymatic assays show whether the material supports dehydrogenase activity. Commercial material is available as the free acid and as salts, and the counterion affects molecular weight, solubility, and how concentrations are calculated.
Laboratory measurement of NAD+ usually begins with rapid sample quenching because the molecule can change form after collection. Enzymatic cycling assays amplify signal through coupled reactions and are suited to small samples. High-performance liquid chromatography with ultraviolet detection separates NAD+ from related nucleotides. Liquid chromatography-mass spectrometry offers higher specificity and can distinguish NAD+ from close analogs. Each method has trade-offs in sensitivity, throughput, and equipment needs, so reported values depend heavily on extraction and detection choices.
| Property | Value | Notes |
|---|---|---|
| Chemical formula | C21H27N7O14P2 | Free acid form; salt and hydrate forms differ in mass. |
| Molar mass | 663.43 g/mol | Anhydrous free acid; counterions and water change the value. |
| Appearance | White to off-white powder | Typical solid reagent; exact color varies by purity and form. |
| Solubility class | Highly water-soluble | Aqueous solutions are acidic; organic solubility is generally limited. |
| Common synonyms | DPN, coenzyme I, NAD | Older literature often uses diphosphopyridine nucleotide or DPN. |
Laboratory handling of NAD+ follows standard practices for hygroscopic fine chemicals. Personnel typically avoid inhalation and skin contact, use gloves and eye protection, and work in a ventilated area. Quality control may include ultraviolet absorbance at the nicotinamide maximum, chromatographic purity, water content, and identity confirmation by mass spectrometry. Because commercial preparations can contain counterions, residual solvents, or related nucleotides, a certificate of analysis helps verify the material. Researchers should confirm that the form supplied matches the intended assay.
Measuring NAD+ in biological samples requires care because the molecule is chemically reactive and present at low concentrations in some tissues. Common approaches include enzymatic cycling assays, high-performance liquid chromatography, and liquid chromatography coupled to mass spectrometry. Each method has different sensitivity and specificity, and sample preparation can affect results. Acidic or alkaline extraction steps are used in some protocols, but the choice depends on the analyte and matrix. No single method is universally optimal for every tissue or fluid.
Solid NAD+ is relatively stable when kept dry, cold, and protected from light. Aqueous solutions are more vulnerable to hydrolysis and can lose activity during repeated freeze-thaw cycles or prolonged storage at ambient temperature. Stability depends on pH, ionic strength, and the presence of degrading enzymes or metal ions. For many laboratory uses, aliquots are stored frozen and thawed only once. Exact degradation rates vary by matrix, so stability should be checked for each application rather than assumed.
In redox reactions, NAD+ accepts a hydride ion, which consists of two electrons and one proton. The hydride adds to the nicotinamide ring at a specific carbon, converting NAD+ into NADH. Dehydrogenase enzymes use this step in glycolysis, the citric acid cycle, and fatty acid oxidation. NADH later donates electrons to the mitochondrial electron transport chain, helping to drive ATP synthesis. The balance between NAD+ and NADH reflects the metabolic state of a cell, and shifts in that balance can alter how pathways operate.
Beyond electron transfer, NAD+ serves as a substrate for enzymes that cleave it and attach its ADP-ribose portion to other molecules. This group includes poly(ADP-ribose) polymerases, CD38, and sirtuins. Such reactions consume NAD+ and can influence its availability for metabolism. Cells replenish NAD+ through a salvage pathway that recycles nicotinamide and through routes starting from tryptophan or vitamin B3 forms. How these synthesis and consumption routes are coordinated across tissues remains an active area of study, and compartment-specific concentrations are difficult to measure directly.
Nicotinamide adenine dinucleotide, abbreviated NAD+, is a dinucleotide built from adenine, nicotinamide, two ribose sugars, and two phosphate groups. The oxidized form carries a positive charge on the nicotinamide ring, while the reduced form, NADH, is neutral. This pair acts as a reversible electron carrier in cells. NAD+ is present in bacteria, plants, animals, and fungi. Its structure allows it to accept and donate electrons without being consumed in the reactions it supports.
Originally, René Just Haüy considered that each chemical compound had a characteristic crystalline form. However, based on his 1808 work with aragonite and his earlier studies of calcite, which are two different forms of calcium carbonate (CaCO3), Haüy had to concede that substances with the same chemical composition but different molecular arrangements could have different crystalline forms. In 1819 Eilhard Mitscherlich discovered the law of isomorphism which states that compounds which contain the same number of atoms, and have similar structures, tend to exhibit similar crystal forms. Mitscherlich carried out the first systematic research on the dependence of crystal forms on their chemical nature. The discovery of isomorphism was the first major step in chemical crystallography and Emil Wohlwill regarded Mitscherlich's work on isomorphism as a milestone in the history of the atomic-molecular theory. The discovery of the phenomena of isomorphism and polymorphism dealt a clear blow to Haüy's crystal structure theory. Mitscherlich's findings were a central consideration of the atomic weight determinations in 1819 by Jöns Jacob Berzelius, a leading proponent of Dalton's atomic theory. Berzelius classified minerals by their chemical composition rather than by their crystal morphology, as was the established practice. Mitscherlich's research, together with the work of Alexis Thérèse Petit and Pierre-Louis Dulong that heat capacities of solids vary with temperature and inversely with atomic weight, led Berzelius to declare them as a positive confirmation of the atomic theory.
=== 9 January === Russia and Ukraine conducted their 36th prisoner swap of the conflict, with each side trading 50 POWs to the other. Ukraine's regional prosecutor's office claimed that an S-300 fired from Belgorod Oblast hit a market in Shevchenkove, killing two women, wounding a child, and damaging a shopping centre. A spokesperson stated that Germany had no plans to provide the Leopard 2 to Ukraine.
Before automated cell counters were introduced, complete blood count tests were performed manually: white and red blood cells and platelets were counted using microscopes. The first person to publish microscopic observations of blood cells was Antonie van Leeuwenhoek, who reported on the appearance of red cells in a 1674 letter to the Proceedings of the Royal Society of London. Jan Swammerdam had described red blood cells some years earlier, but did not publish his findings at the time. Throughout the 18th and 19th centuries, improvements in microscope technology such as achromatic lenses allowed white blood cells and platelets to be counted in unstained samples. The physiologist Karl Vierordt is credited with performing the first blood count. His technique, published in 1852, involved aspirating a carefully measured volume of blood into a capillary tube and spreading it onto a microscope slide coated with egg white. After the blood dried, he counted every cell on the slide; this process could take more than three hours to complete. The hemocytometer, introduced in 1874 by Louis-Charles Malassez, simplified the microscopic counting of blood cells. Malassez's hemocytometer consisted of a microscope slide containing a flattened capillary tube. Diluted blood was introduced to the capillary chamber by means of a rubber tube attached to one end, and an eyepiece with a scaled grid was attached to the microscope, permitting the microscopist to count the number of cells per volume of blood.
=== μ-opioid receptors === In clinical trials, the MOR is the main target of opioid ligand binding. While binding of the opioid to the MOR typically causes analgesia, there can be instances where hyperalgesia occurs. It has been speculated that the opposite analgesic and hyperanalgesic effects are due to different isoforms of the receptor. The MOR is a G protein-coupled receptor with seven transmembrane domains. Variants of the receptor have been discovered and are due to alternative splicing mechanisms. A particular receptor variant, 6TM MOR, has been heavily studied because of its role in nociception. The 6TM MOR is missing residues in the N-terminal region which has implications for the extracellular tail and first transmembrane domain. This causes an excitatory effect compared to the inhibition in the normal seven transmembrane domain receptor because of differences in G-protein activation. Studies on mice have shown silencing of the 6TM MOR variant decreased morphine-induced hyperalgesia which suggested G-protein coupling in the 6TM isoform could be a factor in the development of OIH.
A system of differential equations for concentration or quantity of substance on each compartment can be written, and its parameters represent blood flows, pulmonary ventilation rate, organ volumes etc., for which information is available in scientific publications. Indeed, the description they make of the body is simplified and a balance needs to be struck between complexity and simplicity. Besides the advantage of allowing the recruitment of a priori information about parameter values, these models also facilitate inter-species transpositions or extrapolation from one mode of administration to another (e.g., inhalation to oral). An example of a 7-compartment PBPK model, suitable to describe the fate of many solvents in the mammalian body, is given in the Figure on the right.
Sources: en.wikipedia.org
=== Substrate specificity === Octopine dehydrogenase has at least two structural characteristics that contribute to substrate specificity. Upon binding to NADH, amino acid residues lining either side of the active site within the space between the domains of OcDH act as a "molecular ruler", physically limiting the size of the substrates that can fit into the active site. There is also a negatively charged pocket in the cleft between the two domains that acts an "electrostatic sink" that captures the positively charged side-chain of L-arginine.
==== Modern interpretations ==== The interpretation of dependent origination as mainly referring to mental processes has been defended by various modern scholars such as Eviatar Shulman and Collett Cox. Eviatar Shulman argues that dependent origination only addresses "the way the mind functions in samsara, the processes of mental conditioning that transmigration consists of." He further argues that it "should be understood to be no more than an inquiry into the nature of the self (or better, the lack of a self)." Shulman grants that there are some ontological implications that may be gleaned from dependent origination. However, he argues that at its core dependent origination is concerned with "identifying the different processes of mental conditioning and describing their relations". For Shulman, dependent origination does not "deal with how things exist, but with the processes by which the mind operates." Shulman argues that the general principle of dependent origination deals exclusively with the processes outlined in the lists of nidanas (not with existence per se, and certainly not with all objects). Shulman writes that seeing dependent origination as referring to the nature of reality in general "means investing the words of the earlier teachings with meanings derived from later Buddhist discourse" which leads to a misrepresentation of early Buddhism. Sue Hamilton presents a similar interpretation which sees dependent origination as showing how all things and indeed our entire "world" (of experience) are dependently originated through our cognitive apparatus.
=== Psychological === Common psychological side effects from clonidine include sedation, drowsiness, and dizziness. The sedative effect of intravenous clonidine is dose-dependent and attributed in part to α2B adrenoceptor activation in the thalamus. Sleep disturbance and depressed mood have been reported, and the Australian Medicines Handbook advises caution in people with a history of depression. Less common neuropsychiatric reactions reported with clonidine (i.e., <1%) include disturbed mental state, nightmares, confusion, hallucinations, and delusions.
== Regulation == There are many mechanisms that exist to regulate the expression of system Xc-, although it is not the sole determinant of extracellular glutamate or intracellular glutathione. An example is amino acid deprivation, which triggers up regulation of the transporter. A key regulator is extracellular glutamate; when it becomes excessive, it goes from an excitatory transmitter to an excitotoxin. The inhibition of uptake of extracellular cystine into cells leads to decreased levels of intracellular glutathione which leads to ferroptosis. This regulation may be done through Excitatory Amino Acid Transporters (EAATs), which decrease extracellular glutamate and increase intracellular glutamate in astrocytes. When looking at its structure, xCT seems to be the main determinant for the system's activity. Glutamate and cystine can be transported in both directions, but, generally, more cystine is imported and more glutamate is exported. Extracellular glutamate acts as a competitive inhibitor for cystine uptake via system Xc-.
Mother Eddy deserves a place in the Trinity as much as any member of it. She has organized and made available a healing principle that for two thousand years has never been employed, except as the merest guesswork. She is the benefactor of the age." — Mark Twain, A Biography, by Albert B. Paine, Vol. III, p. 1271."
Sources: en.wikipedia.org
==== Operation Sem Desconto ==== On 23 April 2025, the Federal Police (PF) and the Comptroller General of the Union (CGU) launched Operation Sem Desconto, to combat a criminal scheme that, since 2019, had been promoting the diversion of more than 6.3 billion reais from retirement and pension payments made by the National Institute of Social Security (INSS), by using entities constituted solely for the purpose of including payroll deductions directly in the payment of their benefits, without the beneficiary's authorization. The legal authorization for deduction of association dues directly from payments to retirees and pensioners has existed since 1991. According to the CGU and the Ministry of Justice and Public Security, class entities, such as associations and unions, formalized Technical Cooperation Agreements (ACT) with the INSS, which justified payroll deductions from the agency's beneficiaries. However, the authorization for the deductions was, in many cases, forged. In this way, the CGU began a series of investigations after identifying the surge in the collection of the entities and in the deducted amounts from 2023 onward. Among the reasons for the increase in deductions are the loosening of rules, motivated by lobbies in the National Congress, failures by the INSS in control and oversight, and political appointments to the agency.
In February 2020, bempedoic acid was approved for use in the United States both as a standalone drug (brand name Nexletol) and in a fixed-dose combination with ezetimibe (brand name Nexlizet). The U.S. Food and Drug Administration (FDA) granted the approval of Nexletol to Esperion Therapeutics. The FDA approved bempedoic acid based on evidence from two clinical trials (Trial 1/ NCT02666664 and Trial 2/NCT02991118) of 3009 subjects with high LDL cholesterol and known atherosclerotic cardiovascular disease or HeFH. The trials were conducted in United States, Canada, and Europe.
== Radioactivity == Natural strontium (Sr) is nonradioactive and nontoxic at levels normally found in the environment, but 90Sr is a radiation hazard. 90Sr undergoes β− decay with a half-life of 28.91 years and a decay energy of 546 keV distributed to an electron, an antineutrino, and 90Y, which in turn undergoes β− decay with a half-life of 64.05 hours and a decay energy of 2.28 MeV distributed to an electron, an antineutrino, and occasionally a gamma ray, leaving stable 90Zr. The gamma-emitting branches are so weak that for most purposes 90Sr and 90Y can be considered pure beta particle emitters.
== See also == Organic food Genetically modified food controversies JECFA Genetically modified organisms Dispute settlement in the WTO Pink slime The World According to Monsanto - a documentary about Monsanto's corporate practices
Sources: en.wikipedia.org
NAD+ is a coenzyme found in all living cells. It carries electrons in metabolic reactions and also serves as a substrate for enzymes involved in signaling and DNA repair. Its oxidized and reduced forms are central to energy metabolism.
NAD+ is the oxidized form and NADH is the reduced form. The pair accepts and donates electrons in redox reactions. Their ratio helps indicate the metabolic state of a cell or compartment.
No. Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are precursors that cells can convert into NAD+. They are distinct molecules with different absorption and metabolism profiles.
Common methods include enzymatic cycling assays, HPLC with UV detection, and LC-MS. The choice depends on sample size, specificity needs, and available equipment. Rapid quenching before analysis is important because NAD+ and NADH can interconvert.